Syncytia formation by SARS‐CoV‐2‐infected cells - Institut Pasteur Access content directly
Journal Articles EMBO Journal Year : 2020

Syncytia formation by SARS‐CoV‐2‐infected cells

Julian Buchrieser
Blandine Monel
Hugo Mouquet
Timothée Bruel

Abstract

Severe cases of COVID-19 are associated with extensive lung damage and the presence of infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms regulating the formation of these syncytia are not well understood. Here, we show that SARS-CoV-2-infected cells express the Spike protein (S) at their surface and fuse with ACE2-positive neighboring cells. Expression of S without any other viral proteins triggers syncytia formation. Interferon-induced transmembrane proteins (IFITMs), a family of restriction factors that block the entry of many viruses, inhibit S-mediated fusion, with IFITM1 being more active than IFITM2 and IFITM3. On the contrary, the TMPRSS2 serine protease, which is known to enhance infectivity of cell-free virions, processes both S and ACE2 and increases syncytia formation by accelerating the fusion process. TMPRSS2 thwarts the antiviral effect of IFITMs. Our results show that SARS-CoV-2 pathological effects are modulated by cellular proteins that either inhibit or facilitate syncytia formation.

Domains

Virology

Dates and versions

pasteur-03253133 , version 1 (08-06-2021)

Identifiers

Cite

Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, et al.. Syncytia formation by SARS‐CoV‐2‐infected cells. EMBO Journal, 2020, 39 (23), pp.e106267. ⟨10.15252/embj.2020106267⟩. ⟨pasteur-03253133⟩
68 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More